http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113337449-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-43 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-12 |
| filingDate | 2021-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113337449-B |
| titleOfInvention | Serratia marcescens HL1 strain that can be used to treat Alzheimer's disease and its application |
| abstract | The invention discloses a Serratia marcescens HL1 strain which can be used for treating Alzheimer's disease and its application. , and its amino sequence is shown in SEQ ID NO: 1. The Serratia marcescens HL1 strain of the present invention is used as a biological strain for treating Alzheimer's disease, and its excellent huperzine A-producing high-efficiency expression gene is transferred into other model strains, and more excellent characters are obtained through genetic modification. , and further optimization of the strain can be achieved by mutation breeding. Its research will be of great significance for the industrial production of huperzine A for biosynthesis, the protection of plant resources, the solution of clinical first-line drug needs, and the reduction of medical costs for Alzheimer's disease. |
| priorityDate | 2021-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.